Cargando…

Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis

The development of a targeted therapy would significantly improve the treatment of periodontitis and its associated diseases including Alzheimer’s disease, rheumatoid arthritis, and cardiovascular diseases. Glutaminyl cyclases (QCs) from the oral pathogens Porphyromonas gingivalis, Tannerella forsyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taudte, Nadine, Linnert, Miriam, Rahfeld, Jens-Ulrich, Piechotta, Anke, Ramsbeck, Daniel, Buchholz, Mirko, Kolenko, Petr, Parthier, Christoph, Houston, John A., Veillard, Florian, Eick, Sigrun, Potempa, Jan, Schilling, Stephan, Demuth, Hans-Ulrich, Stubbs, Milton T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948796/ https://www.ncbi.nlm.nih.gov/pubmed/33837744 http://dx.doi.org/10.1016/j.jbc.2021.100263

Ejemplares similares

Tetrahydroimidazo[4,5-c]pyridine-Based Inhibitors of Porphyromonas gingivalis Glutaminyl Cyclase
por: Ramsbeck, Daniel, et al.
Publicado: (2021)

Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2018)

The Bacteroidetes Q-rule and glutaminyl cyclase activity increase the stability of extracytoplasmic proteins
por: Szczęśniak, Katarzyna, et al.
Publicado: (2023)

The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions
por: Cynis, Holger, et al.
Publicado: (2011)

Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
por: Becker, Andreas, et al.
Publicado: (2013)

Natural Products from Microalgae with Potential against Alzheimer’s Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors
por: Hielscher-Michael, Stephanie, et al.
Publicado: (2016)

TLR2 Activation by Porphyromonas gingivalis Requires Both PPAD Activity and Fimbriae
por: Wielento, Aleksandra, et al.
Publicado: (2022)

Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor
por: Linnert, Miriam, et al.
Publicado: (2021)

Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer’s disease-like pathology
por: Gnoth, Kathrin, et al.
Publicado: (2020)

Soluble Variants of Human Recombinant Glutaminyl Cyclase
por: Castaldo, Cristiana, et al.
Publicado: (2013)

In vitro and in silico determination of glutaminyl cyclase inhibitors
por: Tran, Phuong-Thao, et al.
Publicado: (2019)

Combination of the Glutaminyl Cyclase Inhibitor PQ912 (Varoglutamstat) and the Murine Monoclonal Antibody PBD-C06 (m6) Shows Additive Effects on Brain Aβ Pathology in Transgenic Mice
por: Hoffmann, Torsten, et al.
Publicado: (2021)

Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2011)

Honey – a potential agent against Porphyromonas gingivalis: an in vitro study
por: Eick, Sigrun, et al.
Publicado: (2014)

Manipulation of Neutrophils by Porphyromonas gingivalis in the Development of Periodontitis
por: Sochalska, Maja, et al.
Publicado: (2017)

Distinct glutaminyl cyclase expression in Edinger–Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Aβ pathology in Alzheimer’s disease
por: Morawski, Markus, et al.
Publicado: (2010)

Antibiotic Susceptibility Patterns of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis Strains from Different Decades
por: Kulik, Eva M., et al.
Publicado: (2019)

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies
por: Hartlage-Rübsamen, Maike, et al.
Publicado: (2021)

Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase
por: Goulas, Theodoros, et al.
Publicado: (2015)

Smoking alters the antigenicity and infectivity of Porphyromonas gingivalis
por: Zeller, Iris, et al.
Publicado: (2014)

Identification of Glutaminyl Cyclase Genes Involved in Pyroglutamate Modification of Fungal Lignocellulolytic Enzymes
por: Wu, Vincent W., et al.
Publicado: (2017)

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
por: Shang, Qi, et al.
Publicado: (2022)

Purinergic signaling during Porphyromonas gingivalis infection
por: Almeida-da-Silva, Cássio Luiz Coutinho, et al.
Publicado: (2016)

Porphyromonas gingivalis fimbriae
por: Enersen, Morten, et al.
Publicado: (2013)

Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis
por: Ciaston, Izabela, et al.
Publicado: (2022)

Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase
por: Zhao, Xida, et al.
Publicado: (2021)

Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis
por: Johansson, Linda, et al.
Publicado: (2016)

Malaria parasite evades mosquito immunity by glutaminyl cyclase–mediated posttranslational protein modification
por: Kolli, Surendra Kumar, et al.
Publicado: (2022)

Genome Sequence of Porphyromonas gingivalis Strain HG66 (DSM 28984)
por: Siddiqui, Huma, et al.
Publicado: (2014)

A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects
por: Lues, Inge, et al.
Publicado: (2015)

Structural and functional insights into oligopeptide acquisition by the RagAB transporter from Porphyromonas gingivalis
por: Madej, Mariusz, et al.
Publicado: (2020)

BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis–Streptococcus gordonii biofilms
por: Mahmoud, Mohamed Y., et al.
Publicado: (2018)

Human glutaminyl cyclase and bacterial zinc aminopeptidase share a common fold and active site
por: Booth, Rachell E, et al.
Publicado: (2004)

Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy
por: Gillis, John Stuart
Publicado: (2006)

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and target for cancer immunotherapy
por: Logtenberg, Meike E. W., et al.
Publicado: (2019)

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
por: Xu, Chenshu, et al.
Publicado: (2020)

In Vitro and In Vivo Activity of Peptidomimetic Compounds That Target the Periodontal Pathogen Porphyromonas gingivalis
por: Tan, Jinlian, et al.
Publicado: (2018)

Tobacco Smoke Augments Porphyromonas gingivalis - Streptococcus gordonii Biofilm Formation
por: Bagaitkar, Juhi, et al.
Publicado: (2011)

Photoinactivation and Photoablation of Porphyromonas gingivalis
por: Harris, David M., et al.
Publicado: (2023)

How Porphyromonas gingivalis Navigate the Map: The Effect of Surface Topography on the Adhesion of Porphyromonas gingivalis on Biomaterials
por: Ardhani, Retno, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c090845npo3t2maforrs7c9nco